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Abstract: Although magnesium (Mg) is a unique biodegradable metal which
possesses mechanical property similar to that of the natural bone and can be
an attractive material to be used as orthopedic implants, its quick corrosion
rate restricts its actual clinical applications. To control its rapid degradation,
we have modified the surface of magnesium implant using fluoridated
hydroxyapatite (FHA: Ca10(PO4)6OH2 − xFx) through the combined micro-arc
oxidation (MAO) and electrophoretic deposition (EPD) techniques, which was
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presented in our previous paper. In this article, the biocompatibility
examinations were conducted on the coated AZ91 magnesium alloy by
implanting it into the greater trochanter area of rabbits. The results of the in
vivo animal test revealed a significant enhancement in the biocompatibility of
FHA/MAO coated implant compared to the uncoated one. By applying the
FHA/MAO coating on the AZ91 implant, the amount of weight loss and
magnesium ion release in blood plasma decreased. According to the
histological results, the formation of the new bone increased and the
inflammation decreased around the implant. In addition, the implantation of
the uncoated AZ91 alloy accompanied by the release of hydrogen gas around
the implant; this release was suppressed by applying the coated implant. Our
study exemplifies that the surface coating of magnesium implant using a
bioactive ceramic such as fluoridated hydroxyapatite may improve the
biocompatibility of the implant to make it suitable as a commercialized
biomedical product.
Keywords: Bioabsorbable magnesium alloy, Coating, Surface modification,
Fluoridated hydroxyapatite, in vivo

1. Introduction
Bio-metals such as titanium alloys and stainless steels have
been commonly utilized as orthopedic implants due to their mechanical
strength.1 However, mechanical properties of these materials vary
vastly from those of the human bone, which may lead to the “stressshielding” problem.2 Moreover, the corrosion products of some of these
alloys may cause long-standing unfavorable effects.1 Since the metal
implants are used as permanent devices such as pins, screws, nails
and bone plates, they remain as a foreign body to the host tissues
even after the completion of healing process, and may need to be
extracted by a post-surgical procedure. The second surgery not only
increases the health care cost, but it may contribute to the patient's
morbidity.3
Absorbable biocompatible materials may be a proper solution
since they eventually dissolve in body fluid.4,5 Several polymers,
ceramics and nanocomposites have been developed as degradable
biomedical materials.6,7 However, they lack appropriate mechanical
properties and cannot be used for load-bearing applications.2,8
Magnesium (Mg) and its alloys have recently been known as a
bioabsorbable bone implant materials, since they possess mechanical
properties similar to those of the human bone with an appropriate
biocompatibility.9,10 However, in spite of the advantages of magnesium
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alloys, they have not been commercialized yet.11 The foremost
drawback reported for magnesium alloys has been related to their high
corrosion rate in the physiological environment.12,13 For that reason, an
initially low or ideally a controllable absorbable rate is wanted to avoid
further deterioration of the adjacent tissue.14,15
If the magnesium implants are being used to fix damage bone
tissue, they are likely to lose their mechanical integrity earlier than
tissue healing of bone due to their rapid corrosion and low
bioactivity.16,17 Recently, some research has been planned to slow
down the corrosion rate of magnesium alloys.18,19 Surface modification
and coating by various materials has been employed as a proper
approach for controlling the corrosion properties of metals since
decades ago with excellent rate of success.20,21 The reduction of the
corrosion rate of magnesium alloys may also be achieved by
appropriate surface treatment.22,23 If the coating material is bioactive,
it not only decreases the corrosion rate, but it can also improve the
biocompatibility which is necessary for the use of magnesium alloys.24
Hydroxyapatite (HA) with the chemical composition of
Ca10(PO4)6(OH)2 has been extensively used as bioactive coating
materials for hard tissue devices. The replacement of F− ion instead of
OH− group in HA composition gives a bioactive ceramic with the
chemical composition of Ca10(PO4)6OH2 − xFx; where x stands for the
degree of fluoridation which is called fluoridated hydroxyapatite (FHA).
FHA is beneficial to improve some key properties of HA; it has lower
absorbable rate and better bioactivity compared to HA, and hence FHA
has the potential to be used as a decent coating material for
bioabsorbable magnesium alloys.25,26
In addition, the biological properties of a coating may be
improved if it is made in nanostructural configuration similar to the
structure of natural bone.27 Thus, in this paper, we planned to prepare
a nanostructured FHA coating on Mg alloy implants. Electrophoretic
deposition (EPD) is known as an inexpensive and easily applicable
method of coating that has been broadly used for surface coating of
bioactive ceramics on metallic implants including stainless steels,
cobalt and titanium alloys.28 In this paper, we utilized EPD technique
for coating of the FHA layer. However, EPD would be more effective if
it applied on a porous structure. Thus, as an intermediate layer on the
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magnesium alloys, micro-arc oxidation (MAO) has been introduced on
the surface of the Mg substrate. It not only can produce a porous
template for the EPD coating layer, but it also can act as a barrier
layer for corrosion attacks due to the existence of MgO in its chemical
composition.22,29
There has been some research separately on MAO coating,29,30,31
and FHA coating by electrodeposition technique32,33 on magnesium
alloys. In our previous work, we employed a combination of MAO and
EPD techniques for the surface modification of AZ91 magnesium alloy
by FHA coating which exhibits a significant property enhancement of
implants. The coating performance, the bioactivity, and the corrosion
resistance have been discussed in our previous paper.34 In this article,
we have developed our analysis on the in vitro and in vivo
biocompatibility of FHA/MAO coated implants in comparison with both
MAO coated and uncoated AZ91 substrates.

2. Materials and methods
Preparation of FHA/MAO coating on AZ91 magnesium alloy
substrates was explicitly explained in our previously published work in
which the detailed study on the fabrication, characterization, corrosion
behavior and bioactivity of the samples was presented.34 Briefly, plate
samples with dimensions of 20 × 15 × 5 mm3 were cut from an AZ91
magnesium alloy ingot. Afterward, they were ground with SiC papers
to 600 grits and then were sonicated in acetone. The FHA powder was
prepared using sol–gel technique. To prepare FHA, 1.227 g of
phosphorous pentoxide (P2O5) was added into a beaker containing
20 mL ethanol. Another solution including 7 g calcium nitrate
tetrahydrate (Ca(NO3)2·4H2O, Merck) and 20 mL of absolute ethanol
was prepared separately and added to the previous solution. For
incorporation of fluorine ion, 70.28 μl hexafluorophosphoric acid (HPF6)
was added into the mixture. The mixture was stirred for about 20 h to
form a viscous gel. The gel was dried in an oven and heat treated at
600 °C for 1 h. The produced powders were milled for 10 h with the
ball/powder ratio of 10/1 and rotational speed of 250 rpm to achieve
the nanostructured FHA powder.
The MAO process was conducted on a direct current (DC) power
supply. The prepared AZ91 samples and a stainless steel plate were
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placed as the anode and cathode respectively inside an electrolyte
solution composed of 200 g/L Na2SiO3 and 200 g/L NaOH. The voltage
was applied step by step to reach 60 V for half an hour. The coated
samples were removed from the electrolyte solution, cleaned with
acetone and dried at room temperature which was approximately
25 °C.
To perform the EPD process, the powder was used in asreceived condition to produce EPD suspension containing 100 g/L of
FHA particles in methanol. The dispersion process was carried out
using ultrasonication and magnetic stirring. In order to disperse the
particles inside the solution, the prepared suspension was placed into
an ultrasonic bath for about 20 min. Afterwards, the dispersion process
was carried out using magnetic stirring. The MAO sample and a
graphite rod were placed at the location of cathode and anode,
respectively. Electrophoretic deposition was started by setting the
constant voltage at 100 V, deposition time of 3 min and electrode
separation of 2 cm.
The size of produced FHA nanoparticles was measured using a
transmission electron microscope (TEM: JEOL JEM-2100). The surface
crystal structure of the samples (before and after the immersion test)
was analyzed using a scanning electron microscope (SEM: Philips XL
30: Eindhoven) equipped with energy-dispersive X-ray spectroscopy
(EDX). A laser scanning microscope (Keyence, VK X100/X200),
equipped with a VK analyzer was used in order to observe the surface
of coated samples. An adhesion tester (PosiTest AT-A, USA) was
employed to determine the adherence strength of coatings on the
substrate.
During the cell culture test, cell viability, pH values and Mg ion
release of samples in the culture media were measured. For cell
viability evaluation, L-929 cell line was cultured in 89% Dulbecco's
modified Eagle's medium (DMEM, Gibco) supplemented with 10% fetal
bovine serum (FBS, Gibco) and 1% penicillin streptomycin. The
samples were sterilized and the cells were seeded onto the samples.
Cell viability was evaluated after 2, 5, and 7 days of culture times. For
this purpose, at each time point, the medium was replaced by MTT
solution and the samples were incubated in this solution for 4 h.
Finally, the medium was replaced by dimethylsulfoxide (DMSO). A
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microplate reader measured the absorbance of samples. The cell
viability was expressed as ODsample / ODcontrol ∗ 100%, where ODsample
and ODcontrol were the optical density of the sample and the control,
respectively. For the control group, cells were cultured on tissue
culture polystyrene plate filled with DMED. In addition, the pH values
and the Mg ion concentrations of the medium were evaluated. Analysis
of variance (ANOVA) was performed for the statistical analysis and the
statistical significance was defined as p < 0.05.
For in vivo animal examinations, the implants were machined in
rod shape with 3 mm diameter and 6 mm length. Adult rabbits were
used in our study and the surgical procedure was conducted according
to the requirements of the University Ethics Committee in the Animal
Unit. The rabbits were anesthetized with Ketamine, Xylazine and
Acepromazine. After anesthesia, the operation site was shaved and
decortication was carried out. A hand driller was utilized to make a
hole of 3 mm diameter into the greater trochanter area of rabbits. The
rod samples were implanted inside the holes and the wound was
sutured layer-by-layer. All rabbits received an injection of antibiotics at
the end of the operation. The rabbits were euthanized after 2 months.
Meanwhile, the X-ray radiography and blood test were performed
during this period. Then, the bone samples including the implants were
taken out to detect the new bone formation around the implants via
histological analysis. For this purpose, the bone samples were
decalcified by nitric acid and were stained with Hematoxylin and Eosin
(H&E). A light microscope was utilized to observe the changes in bone
structure around the implants.

3. Results and discussion
As can be seen in the TEM image of Fig. 1a, the size of the FHA
nanoparticles are in the range of 50–100 nm with agglomerative
configuration. The XRD pattern of nanoparticles in Fig. 1b represents
the expected crystallized peaks of FHA. According to SEM image of
Fig. 1c, the surface of MAO coating has a rough morphology containing
several pores. This structure was formed by releasing the gas bubbles
in molten oxide during the arcs. XRD pattern of the MAO coating in
Fig. 1d detects Mg, MgO and Mg2SiO4 peaks in the MAO coating. MgO
is formed by dissolving Mg2 + from the AZ91 substrate and its chemical
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reaction with the O2 − from the electrolyte. At higher temperature
during the micro-arc oxidation process, both SiO2 and MgO are
presented and form Mg2SiO4 (forsterite). MgO and Mg2SiO4 protect the
substrate from the corrosion attacks and have positive effects on
enhancing the bioactivity. The surface morphology of the FHA coating
is illustrated in Fig. 1e. According to the SEM micrograph of FHA
coating in this figure, it has a porous surface with a netlike structure.
It has been suggested that this configuration can be supportive for cell
attachment and proliferation, and may improve the biological fixation
of the implant to the surrounding bone tissue. As can be seen in the
XRD pattern of FHA coating in Fig. 1f, besides the diffraction peaks
from the MAO (Mg, MgO and Mg2SiO4), the diffraction peaks from FHA
were also detected, indicating that FHA has been coated as the main
phase on the surface of MAO.

Fig. 1. TEM image of FHA particles (a), XRD pattern of FHA particles (d), SEM
micrograph of MAO coating (c), XRD pattern of MAO coating (d), SEM micrograph of
FHA coating (e), and XRD pattern of FHA coating (f).

The cross-sectional morphologies of the AZ91 (a), MAO (b) and
FHA/MAO coated (c) samples have been presented in Fig. 2 which
indicate that the thicknesses of MAO and FHA coating are
approximately 100 and 250 μm, respectively. The FHA, with a rough
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morphology, has been deposited on the surface of MAO coating.
Different phases including AZ91, MAO coating and FHA/MAO coating
can be observed in SEM micrographs. The EDS line-scan analysis as an
inset in Fig. 2c shows that the FHA coating mainly contains of Ca, Mg,
and P elements. As can be seen in Fig. 2c, the intensities of Ca and P
decrease and the intensity of Mg increases from FHA/MAO coating to
the AZ91 substrate, as the coating layer contains Ca and P. According
to the laser scanning microscopy images (Fig. 2d, e, f), the MAO
coating has bumpy morphology compared to the AZ91 substrate with
roughness of about 15 μm. The roughness of FHA/MAO coating is
approximately 200 μm which is significantly more than that of the MAO
coating. Several islands (red color) with the approximate height of
500 μm can be observed in Fig. 2f. Small submicron surface roughness
can be observed on the FHA/MAO coating according to the line scan
profilometry analysis (Fig. 2i). The measured roughness values for red
and blue islands are approximately 7 and 11 μm for red and blue
islands, respectively.

Fig. 2. Cross-sectional morphology of the AZ91 (a), MAO (b) and FHA/MAO (c) coated
samples, three dimensional laser scanning microscopy images of the AZ91 (d), MAO
(e) and FHA/MAO (f) coated samples, and surface profilometry analysis of AZ91 (g),
MAO (h) and FHA/MAO (i) coated samples.

Since the MAO coating has a high strength metallurgical binding
with the AZ91 substrate, the adhesion tester was not able to measure
the adherence strength. However, the adherence strength between the
FHA/MAO coating and MAO coating was measured 6.5 ± 0.3 MPa.
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Table 1 presents the results of the cell viability in 2, 5, and
7 days of culture times. For all samples, the cell viability increased
with culture time. The cell viability of AZ91 sample increased from
50% after 2 days to 58% after 7 days of culture time. The cell viability
of MAO sample increased from 70% after 2 days to 85% after 7 days
of culture time and for FHA/MAO coated sample, the cell viability
increased from 160% after 2 days of culture time to 175% after
7 days of incubation. Thus, the FHA/MAO coated sample presented a
superior cell viability compared to others. This indicated that the
coated samples have significantly more initial cytocompatibility than
the uncoated sample. It is worth mentioning that the FHA/MAO coated
sample has shown cell viability over 100% in all culture times.
According to the cell viability calculation in the present study (cell
viability = ODsample / ODcontrol × 100), the cell viability is over 100%
when the optical density of a sample (ODsample) is more than that of the
control group (ODcontrol) which denotes that the sample possesses more
viable cells compared to the control group confirming the good
proliferation of cells on that sample. In the present study, the amount
of cell viability of FHA/MAO coated sample (160% after 2 days and
175% after 7 days) indicates that the sample was not cytotoxic, and
the FHA/MAO coated sample facilitated the cell proliferation.
Table 1. The results of cell viability in 2, 5, and 7 days of culture times.
Samples

2 (days)

5 (days)

7 (days)

AZ91 magnesium alloy

50 ± 3

55 ± 5

58 ± 7%

MAO coating

70 ± 5

80 ± 6

85 ± 7%

FHA/MAO coating

160 ± 9

170 ± 10

175 ± 9%

The pH values of DMEM culture medium during the cell culture
test for AZ91, MAO, and FHA/MAO coated samples are shown in
Fig. 3a. According to Fig. 3a, the pH value of AZ91 sample after 2 days
was 8.8 which reached 9.5 after 7 days. The pH value of MAO sample
after 2 days and 7 days was 8.1 and 8.8, respectively. For the
FHA/MAO coated sample, the pH value changed from 7.8 after 2 days
to 8.1 after 7 days. The pH increase is mostly as a result of the
releasing the OH− group in the medium. The less increase of pH value
of the medium containing the MAO and FHA/MAO coated sample for
the period of the cell culture shows a comparatively slow corrosion and
an improvement of the corrosion resistance of MAO and FHA/MAO
coating. Fig. 3b shows the Mg ion release of the samples during the
Materials Science and Engineering: C, Vol 48 (March 2015): pg. 21-27. DOI. This article is © Elsevier and permission has
been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article
to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

10

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

cell culture test. According to Fig. 3b, the Mg ion concentration after
2 days for AZ91, MAO, and FHA/MAO coated samples was 22, 18, and
13 ppm, respectively. After 7 days, the Mg ion concentration increased
to 30, 25, and 17 ppm for AZ91, MAO, and FHA/MAO coated samples,
respectively. Thus, according to the results, for all samples the Mg ion
concentration increased with the culture time, however, the lowest Mg
ion concentration was found for FHA/MAO coated samples indicating
the least corrosion rate compared to the others.

Fig. 3. pH values of DMEM culture medium (a) and Mg ion release (b) of AZ91, MAO,
and FHA/MAO coated samples during the cell culture test in DMEM culture medium
showing the corrosion behavior of samples during the cell culture test.

The environmental variations including pH changes and Mg ion
release in the culture medium affect the cell viability. The fast increase
of pH value leads to less viability and proliferation of cells. In addition,
Mg ion release is accompanied by the production of hydrogen bubbles
from the surface. The hydrogen evolution can be an important obstacle
for cell attachment.35 The surface modification of magnesium substrate
can significantly decrease the corrosion rate leading to less change in
pH value and Mg ion release.33 In our study, FHA/MAO coating on the
magnesium substrate reduces the pH increase and Mg ion release
leads to the best cell viability compared to other samples. Moreover,
having calcium element in the chemical composition of FHA coating
can be helpful on the cellular behavior, as it improves the chemical
signaling of the cells and absorbs fibronectin and vitronectin proteins
which are crucial elements on the biological function of the cells.36
The AZ91 (a), MAO (d), and FHA/MAO coated (g) samples were
implanted into the greater trochanter of rabbits and the surgery
images are presented in Fig. 4. According to the post-operation
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veterinary examinations, clinical signs as a result of swelling, pain or
alteration were not detected. The formation of gas bubbles below the
skin was not detected and good wound healing was observed after the
surgery. The X-ray radiography images from AZ91 (Fig. 4b), MAO
(Fig. 4e) and FHA/MAO coated (Fig. 4h) implants were taken off the
rabbits 2 weeks after the surgery. The gas bubbles around the AZ91
implants (black area) were more than other implants due to the higher
corrosion rate, however, almost no gas bubbles were found around the
FHA/MAO coated implants. Note that the absorption of hydrogen gas
usually occurs in longer times as a result of decreasing the corrosion
rate due to the formation of corrosion products on the surface.35 Other
researchers have also mentioned that the visible subcutaneous
hydrogen bubbles appeared in the first days after the surgery and
disappeared after 2–3 weeks.37 After euthanizing the rabbits,
pathological examinations were carried out on the bone tissue around
implantation region of the AZ91 (Fig. 4c), MAO (Fig. 4f), and FHA/MAO
coated (Fig. 4i) implants. Comparing the histological images of
different samples, one may notice that the new bone formed around
the FHA/MAO coated implants was more than the others and
conversely the inflammation was less than others. The level of the
volume percentage of new bone formation around the implants was in
the following order: FHA/MAO coating (60%) > MAO (31%) > AZ91
(27%). Lower release of hydrogen bubbles around the FHA/MAO
coated implants due to the lower corrosion rate led to the more bone
formation and less inflammation compared to other samples.
Furthermore, the existence of Ca and P elements in the chemical
composition of FHA can stimulate the osteoblastic cells and improve
the osteoconductivity.24 Immune response to implants generally
comprises the hypersensitivity related to implants.38 Observation of
hypersensitivity reactions in surrounding tissues upon discharging the
corrosion products suggests that there is a correlation between
corrosion and metal hypersensitivity.39 Moreover, metals suffering
from wear process release wear particles which may provoke
undesirable reactions in patients and cause inflammation which
consequently may loosen the implant.40 Phagocytic cells take up
corrosion products and particles, and generate pro-inflammatory
cytokines. The inflammation endures by releasing more particles from
the implant, and possibly by self-perpetuating cytokine-driven
procedures. The pro-inflammatory surrounding stimulates the
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generation of bone resorbing cells, and consequently the patient may
experience severe bone loss and implant loosening, followed by pain
and limitation of motion as symptoms of metallosis.41 Although, the
microscopic inflammation could be observed in the bone tissue around
the implants of our experiment according to histological images, there
was no sign of macroscopic inflammations in veterinary examinations.

Fig. 4. The surgery images of AZ91 (a), MAO (d), and FHA/MAO coated (g) samples,
the X-ray radiography images from AZ91 (b), MAO (e), and FHA/MAO coated (h)
samples and the histological analysis of AZ91 (c), MAO (f), and FHA/MAO coated (i)
samples implanted into the greater trochanter of rabbits.

The results of the blood test to detect the changes of serum
magnesium level in blood plasma for AZ91, MAO, and FHA/MAO coated
implants before implantation and after 2 weeks, 1 and 2 months of
post-operation are presented in Fig. 5. Before the surgery, the serum
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magnesium value was the same for all rabbits. Although it increased
due to the corrosion of magnesium substrate, it was within the normal
range of physiological magnesium level (20 ppm).42 However,
according to the results, the difference between serum magnesium
value before and after the surgery for FHA/MAO coated implants was
less than others.

Fig. 5. The results of the blood test to detect the changes of serum magnesium level
in blood plasma for AZ91, MAO, and FHA/MAO coated implants before implantation
and after 2 weeks, 1 and 2 months of post-operation.

The weight variation of implants after euthanizing the rabbits
was measured. The results indicated that the weight losses of AZ91,
MAO, and FHA/MAO coated implants were 25, 16, and 4 mg/cm2,
respectively. Thus, the weight loss of the FHA/MAO coated implant was
significantly less than that of the other implants. It is worth noting that
a large amount of magnesium ions is released during the corrosion of
implants. However, no considerable increase is observed in the serum
magnesium value. This may be due to the regulation of magnesium
ions in the kidney and their excretion in the urine.24

4. Conclusion
In order to enhance the corrosion resistance of magnesium
implants, we have modified the surface of AZ91 magnesium alloy
using fluoridated hydroxyapatite through the micro-arc
oxidation/electrophoretic deposition (MAO/EPD) technique. In
continuation with our previous work, we completed our study on the
coated and uncoated Mg implants by biocompatibility analyses
including in vivo examinations. The results confirmed that the
FHA/MAO coating noticeably improved the biocompatibility of AZ91
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magnesium alloy implant. Thus, we recommend the bioabsorbable
FHA/MAO coated Mg implant as a suitable candidate for future clinical
orthopedic applications.
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